Unveiling the Healing Potential of Stem Cells: The Promising Role of Secretome Therapy in the Treatment of Pulmonary Degenerative Disorders-A Comprehensive Systematic Review.
{"title":"Unveiling the Healing Potential of Stem Cells: The Promising Role of Secretome Therapy in the Treatment of Pulmonary Degenerative Disorders-A Comprehensive Systematic Review.","authors":"Hanane Noroozi, Reza Pakzad","doi":"10.2174/011574888X373765250710105821","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objective: </strong>Stem cell-based therapy has emerged as a promising avenue for treating pulmonary degenerative disorders due to its remarkable capacity for self-renewal and differentiation into various cell types. However, concerns regarding undesired differentiation and tumorigenicity have raised questions about the safety and efficacy of cell-based therapy. The aim of the present systematic review study was to determine the therapeutic effectiveness of stem cell secretome in mitigating three pulmonary degenerative diseases, including Acute Lung Injury (ALI), Idiopathic Pulmonary Fibrosis (IPF), and Bronchopulmonary Dysplasia (BPD).</p><p><strong>Method: </strong>A comprehensive search was carried out on international databases, including MEDLINE, Scopus, Web of Science, PubMed, and Embase, using related keywords according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA-2020) guidelines.</p><p><strong>Results: </strong>Of 1541 retrieved studies, 136 articles were included in the present systematic review. The therapeutic effects of stem cells are primarily attributed to their paracrine secretions, specifically bioactive molecules known as the secretome, which includes exosomes and extracellular vesicles. Secretome-based therapy shows great promise in maximizing the healing potential of stem cells. However, several challenges and limitations hinder its widespread application, including scalability issues, delivery challenges, difficulty in controlling dosage, and the lack of standardized production protocols. As it is a novel therapeutic approach, its complex composition, mechanism of action, and variability in responses from the body, as well as long-term safety, remain unknown and pose challenges that necessitate further investigation and well-designed clinical trials.</p><p><strong>Conclusion: </strong>The secretome exerts its protective and therapeutic effects by regulating various processes, including inflammation, oxidative stress, cell apoptosis, macrophage polarization, growth factor signaling pathways, immune cell activation, TGF-β signaling pathways, angiogenesis, structural attenuation, fibrosis resolution, pulmonary functional improvement, and alveolarization.</p>","PeriodicalId":93971,"journal":{"name":"Current stem cell research & therapy","volume":" ","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2025-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current stem cell research & therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/011574888X373765250710105821","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background and objective: Stem cell-based therapy has emerged as a promising avenue for treating pulmonary degenerative disorders due to its remarkable capacity for self-renewal and differentiation into various cell types. However, concerns regarding undesired differentiation and tumorigenicity have raised questions about the safety and efficacy of cell-based therapy. The aim of the present systematic review study was to determine the therapeutic effectiveness of stem cell secretome in mitigating three pulmonary degenerative diseases, including Acute Lung Injury (ALI), Idiopathic Pulmonary Fibrosis (IPF), and Bronchopulmonary Dysplasia (BPD).
Method: A comprehensive search was carried out on international databases, including MEDLINE, Scopus, Web of Science, PubMed, and Embase, using related keywords according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA-2020) guidelines.
Results: Of 1541 retrieved studies, 136 articles were included in the present systematic review. The therapeutic effects of stem cells are primarily attributed to their paracrine secretions, specifically bioactive molecules known as the secretome, which includes exosomes and extracellular vesicles. Secretome-based therapy shows great promise in maximizing the healing potential of stem cells. However, several challenges and limitations hinder its widespread application, including scalability issues, delivery challenges, difficulty in controlling dosage, and the lack of standardized production protocols. As it is a novel therapeutic approach, its complex composition, mechanism of action, and variability in responses from the body, as well as long-term safety, remain unknown and pose challenges that necessitate further investigation and well-designed clinical trials.
Conclusion: The secretome exerts its protective and therapeutic effects by regulating various processes, including inflammation, oxidative stress, cell apoptosis, macrophage polarization, growth factor signaling pathways, immune cell activation, TGF-β signaling pathways, angiogenesis, structural attenuation, fibrosis resolution, pulmonary functional improvement, and alveolarization.
背景和目的:基于干细胞的治疗由于其显著的自我更新和分化成各种细胞类型的能力而成为治疗肺退行性疾病的一种有前途的途径。然而,对不期望的分化和致瘤性的担忧引发了对细胞治疗安全性和有效性的质疑。本系统综述研究的目的是确定干细胞分泌组在减轻三种肺退行性疾病的治疗效果,包括急性肺损伤(ALI)、特发性肺纤维化(IPF)和支气管肺发育不良(BPD)。方法:根据PRISMA-2020 (Preferred Reporting Items for Systematic Reviews and meta - analysis)指南,使用相关关键词对MEDLINE、Scopus、Web of Science、PubMed、Embase等国际数据库进行综合检索。结果:在1541篇检索研究中,136篇文章被纳入本系统综述。干细胞的治疗作用主要归因于它们的旁分泌,特别是被称为分泌组的生物活性分子,包括外泌体和细胞外囊泡。基于分泌体的治疗在最大限度地发挥干细胞的愈合潜力方面显示出巨大的希望。然而,一些挑战和限制阻碍了其广泛应用,包括可扩展性问题、交付挑战、控制剂量的困难以及缺乏标准化的生产方案。由于它是一种新颖的治疗方法,其复杂的成分、作用机制、机体反应的可变性以及长期安全性仍然未知,因此需要进一步的研究和精心设计的临床试验。结论:分泌组通过调节炎症、氧化应激、细胞凋亡、巨噬细胞极化、生长因子信号通路、免疫细胞活化、TGF-β信号通路、血管生成、结构衰减、纤维化消退、肺功能改善、肺泡形成等过程发挥保护和治疗作用。